Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapSucker Stock

REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Opening of $500,000 Line of Credit

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250820:nRST9849Va&default-theme=true

RNS Number : 9849V  MyCelx Technologies Corporation  20 August 2025

20 August 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company")

 

Opening of $500,000 Line of Credit

 

MYCELX Technologies Corporation (AIM: MYX), the clean water and clean air
technology company, is pleased to announce that it has opened a line of credit
("LOC") with TriState Capital Bank which will allow the Company to access up
to $500,000.

 

The proceeds will enable MYCELX to increase funds available for sales and
marketing, trial equipment, and bridging project accounts receivable as the
Company expands and accelerates its reach to meet the growing demand for its
technology in PFAS remediation and Produced Water treatment.

 

The LOC has the following terms: Floating rate basis Adjusted One Month Term
of the Secured Overnight Financing Rate (SOFR) plus 1.5% margin, however the
rate will never be below 2.49%. As of 15 August 2025, the SOFR rate is 4.36%.
The LOC has been personally guaranteed by MYCELX's Chief Executive Officer
Connie Mixon for no cost to the Company or otherwise.

 

Connie Mixon, CEO, commented:

 

"In securing this new LOC, MYCELX is placing itself in a stronger position to
pursue its robust opportunity pipeline and further capitalize on recent
successful trials and installations. The LOC provides flexibility for the
Company to increase marketing spend and trials while bridging milestone
projects to completion. The Company believes recognition of the performance of
its technology globally is accelerating and targeted marketing in the PFAS and
Produced Water markets will positively impact conversion of RFQs to
contracts."

 

The provision of the guarantee constitutes a related party transaction under
AIM Rule 13 of the AIM Rules for Companies. The independent directors, being
Tom Lamb, Hal Alper and Andre Schnabl, having consulted the Company's
Nominated Adviser, Cavendish Capital Markets Limited, consider the terms of
the guarantee to be fair and reasonable insofar as shareholders are concerned.

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                                      Tel: +1 888 306 6843

 Kim Slayton, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

 Giles Balleny / Callum Davidson (Corporate Finance)                    Tel: +44 20 7220 0500

 Jamie Anderson (Corporate Broking)

 Jasper Berry / Michael Johnson (Sales)

 Celicourt Communications (Financial PR)

 Mark Antelme                                                           Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKCBQKBKBCFD

Recent news on Mycelx Technologies

See all news